Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia
Annals of Hematology（2023）
关键词
chronic myeloid leukemia,olverembatinib,successful therapeutic strategy,mixed-phenotype
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要